Table 2 Base case results of liraglutide versus without liraglutide (in Egyptian Pounds)

Cost of liraglutide acquisition

114,072,451

26,528,477 USD

152,096,602

35,371,302 USD

190,120,752

44,214,128 USD

456,289,805

106,113,908 USD

Cost of standard of care by substitution^a

(13,000,266)

3,023,317 USD

(17,333,688)

4,031,090 USD

(21,667,110)

5,038,862 USD

(52,001,064)

12,093,270 USD

Drug cost

101,072,185

23,505,159 USD

134,762,914

31,340,212 USD

168,453,642

39,175,265 USD

404,288,741

94,020,637 USD

Non-fatal myocardial infarction

(2,220,074)

516,296 USD

(2,960,099)

688,395 USD

(3,700,124)

860,493 USD

(8,880,297)

2,065,185 USD

Non-fatal stroke

(953,906)

221,838 USD

(1,271,875)

295,784 USD

(1,589,844)

369,731 USD

(3,815,625)

887,354 USD

Hospitalization for heart failure

(3,499,637)

813,869 USD

(4,666,183)

1,085,158 USD

(5,832,729)

1,356,448 USD

(13,998,549)

3,255,476 USD

Coronary revascularization

(1,719,736)

399,938 USD

(2,292,982)

533,251 USD

(2,866,227)

666,564 USD

(6,878,946)

1,599,754 USD

Retinopathy

217,033

50,472 USD

289,377

67,296 USD

361,721

84,121 USD

868,131

201,890 USD

Nephropathy

(11,703,224)

2,721,680 USD

(15,604,298)

3,628,906 USD

(19,505,373)

4,536,133 USD

(46,812,895)

10,886,719

Hospitalization_unstable angina pectoris

(277,509)

64,536 USD

(370,012)

86,049 USD

(462,515)

107,561 USD

(1,110,037)

258,148 USD

Mortality

(37,980,744)

8,832,731 USD

(50,640,992)

11,776,974 USD

(63,301,240)

14,721,218 USD

(151,922,975)

35,330,924 USD

Medical costs

(58,137,798)

13,520,418 USD

(77,517,064)

18,027,224 USD

(96,896,330)

22,534,030 USD

(232,551,192)

54,081,672 USD

Total costs PPPM

29

6.74 USD

39

9.06 USD

49

11.39 USD

39

9.06 USD